Applied Therapeutics, Inc. (APLT): Price and Financial Metrics


Applied Therapeutics, Inc. (APLT): $17.32

1.64 (+10.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

APLT Stock Price Chart Interactive Chart >

Price chart for APLT

APLT Price/Volume Stats

Current price $17.32 52-week high $29.80
Prev. close $15.68 52-week low $13.04
Day low $15.64 Volume 128,000
Day high $17.79 Avg. volume 105,709
50-day MA $16.54 Dividend yield N/A
200-day MA $19.54 Market Cap 453.40M

Applied Therapeutics, Inc. (APLT) Company Bio


Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY


APLT Latest News Stream


Event/Time News Detail
Loading, please wait...

APLT Latest Social Stream


Loading social stream, please wait...

View Full APLT Social Stream

Latest APLT News From Around the Web

Below are the latest news stories about Applied Therapeutics Inc that investors may wish to consider to help them evaluate APLT as an investment opportunity.

Is Applied Therapeutics (NASDAQ:APLT) Using Debt Sensibly?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yahoo | September 17, 2021

Applied Therapeutics Stock Drops On Delayed NDA Submission For Its Lead Candidate

Applied Therapeutics Inc (NASDAQ: APLT ) has reported initial biomarker data from the pediatric ACTION-Galactosemia

Business Insider Markets | September 9, 2021

Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids

Substantial and statistically significant reduction in plasma galactitol Baseline analysis demonstrates clear relationship between plasma galactitol level and severity of disease in pediatric Galactosemia patients NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported initial biomar

Yahoo | September 9, 2021

Applied Therapeutics Reports Second Quarter 2021 Financial Results

NDA submission for AT-007 in Galactosemia expected in Q3 2021; commercial preparations ongoing Ended Q2 2021 with a strong balance sheet with $125.6 million in cash and cash equivalents and short-term investments NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial result

Yahoo | August 12, 2021

Applied Therapeutics Added to Russell Microcap Index

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company has joined the Russell Microcap Index. The newly reconstituted index took effect after the market close on Friday,

Wallstreet:Online | June 28, 2021

Read More 'APLT' Stories Here

APLT Price Returns

1-mo 12.03%
3-mo -16.65%
6-mo -4.89%
1-year -12.39%
3-year N/A
5-year N/A
YTD -21.31%
2020 -19.32%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8141 seconds.